梯瓦制药三季度每股收益、净收入均高于预期,上调全年每股收益展望

老虎资讯综合
Nov 05, 2025

梯瓦制药 第三季度非GAAP每股收益为0.78美元,高于去年同期的0.69美元。分析师此前预期为0.68美元。

截至9月30日的季度净收入为44.8亿美元,高于去年同期的43.3亿美元。分析师此前预期为43.4亿美元。

公司目前预计2025年非GAAP每股收益为2.55美元至2.65美元,高于此前预期的2.50美元至2.65美元。分析师此前预期为2.57美元。

预计本年度营收为168亿美元至170亿美元,与此前预期的168亿美元至172亿美元基本持平。分析师此前预期为168.3亿美元。

梯瓦制药盘前拉升大涨近12%。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10